Last update:

Coronavirus (COVID-19)

Diseases, Conditions, Syndromes

People who are 'double jointed' may be at heightened risk of long COVID, says study

People who are "double-jointed," a condition formally known as generalized joint hypermobility, may be at heightened risk of long COVID, suggests a case-control study published in the open access journal BMJ Public Health.

Cell & Microbiology

Discovery of how COVID-19 virus replicates opens door to new antiviral therapies

A new study looking at the replication stage of the SARS-CoV-2 virus that causes COVID-19 reveals important mechanisms in its replication that could be the foundation for new antiviral therapies.

COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.

Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.

More information: WHO, CDC, global cases.

Follow us on Google News for the latest updates on the coronavirus.

Diseases, Conditions, Syndromes

Researchers develop more broadly protective coronavirus vaccine

Scientists have been searching for the optimal coronavirus vaccine since the COVID-19 pandemic started. The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; ...

Diseases, Conditions, Syndromes

COVID-19 antibody discovery could explain long COVID

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of ...

Diseases, Conditions, Syndromes

Study confirms effectiveness of bivalent COVID-19 vaccine

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to ...